Target Industry: Pharmacogenomics

Pharmacogenomics, the study of how genes affect the way individuals respond to drugs, has the potential to dramatically change the way in which medicine is developed and practiced. Today, only a handful of pharmacogenomics-based products are on the market—but within 10 years they are expected to be a part of mainstream medical practice. What might be the clinical impacts of pharmacogenomics? What will be the benefits of pharmacogenomics products, as well as the challenges involved in their development and market acceptance?

Learn more here.